Does AHK-Cu Actually Regrow Hair?
Published by AmpleLab Research
Unlike some of the compounds we've had to debunk fabricated citations for, AHK-Cu's foundational research is real, and we cite it often: Pyo et al., 2007, the study that first demonstrated AHK-Cu's activity on human hair follicles. Real study, real journal, real finding. That's not the question this article is asking.
The question is what that study actually measured, and whether it supports the specific claim "AHK-Cu regrows hair" the way that phrase gets used in marketing. It's worth separating those two things, because a real study and an accurate claim about what it shows aren't automatically the same thing.
What Pyo 2007 Actually Did
Human hair follicles were surgically extracted and cultured in a dish (organ culture), then exposed to AHK-Cu at various concentrations. The study measured whether follicles maintained hair shaft elongation for longer under culture conditions and looked at markers of follicle keratinocyte proliferation. No human being had AHK-Cu applied to their own, attached, living scalp at any point in this research.
This distinction, cultured follicles versus a living scalp, matters more than it might first appear. A follicle sitting in a dish is disconnected from the systemic factors that govern hair loss and growth in an actual person: the androgen environment, the immune system, blood supply from a functioning circulatory system, mechanical stress, and everything else about being attached to someone's head. Organ culture is a genuinely useful way to isolate a compound's direct effect on follicle cells specifically, which is exactly what it was designed to do here. It isn't a way to predict what happens when that same compound is applied topically to intact skin on a living person, where it first has to penetrate the stratum corneum, diffuse through the skin, and reach follicle cells embedded within the biology of a living scalp.
"Stimulates Follicle Cells in Culture" Is Not "Regrows Hair"
"AHK-Cu regrows hair" is a claim about a visible outcome in a person: more density, more coverage, thicker strands, over some realistic timeframe. What Pyo 2007 actually demonstrated is a claim about cellular behaviour in an artificial system: follicle cells proliferating and hair shafts elongating for longer under laboratory conditions. The second is a genuinely interesting and real finding. It is not the same category of claim as the first, and moving from one to the other requires a step the research doesn't take: showing that the effect survives topical application, penetration, and the full biological context of an actual scalp.
This isn't a reason to dismiss the finding, it's a reason to describe it accurately. "AHK-Cu has been shown to stimulate human hair follicle cells in laboratory culture" is a true, checkable statement. "AHK-Cu regrows hair" implies a level of proof this specific study, on its own, doesn't provide. The gap between calibrated and overstated language here is covered in more general terms in our article on what is a cosmetic vs a medicine, which explains why the distinction isn't just semantic.
Why the Finding Still Matters, Properly Framed
Organ culture studies are a standard, respected part of early-stage dermatology and hair research; they're how compounds get identified as worth investigating further, not a lesser form of evidence to be dismissed. AHK-Cu having a positive signal in this kind of study is a genuine reason for interest, and it's why AHK-Cu was selected as AmpleLab's hair-specific active rather than a compound with no follicle-level research at all.
What it isn't is a substitute for the next stage of evidence this compound doesn't yet have: a topical human trial measuring actual scalp outcomes over time. Until that exists, the honest position is that AHK-Cu is mechanistically promising at the cellular level and clinically untested at the level that would justify a "regrows hair" claim.
Frequently Asked Questions
So is the Pyo 2007 study fake or exaggerated?
No, it's a real, published, peer-reviewed study, and it found what it found. The issue isn't the study itself; it's how "AHK-Cu stimulated follicle cells in organ culture" gets compressed into "AHK-Cu regrows hair" in marketing copy, which overstates what was actually shown.
Has AHK-Cu ever been tested on a living person's scalp?
Not in any published clinical trial we're aware of. The available research is limited to cultured follicles in a laboratory setting. No topical human trial exists.
Why does AmpleLab sell AHK-Cu if it hasn't been tested in people?
Because it's the compound with the most direct, hair-specific cellular research of the actives available to us, even though that research is early-stage. We think that's a legitimate reason to formulate 1% AHK-Cu Hair and Scalp Serum around it. It isn't a reason to describe it with claims the underlying evidence doesn't support, which is the point of this article.
What would count as real evidence that AHK-Cu regrows hair?
A randomised, controlled human trial applying topical AHK-Cu to the scalp and measuring density or coverage change against a placebo over a realistic timeframe, the same standard by which licensed hair-loss treatments such as minoxidil were established. That doesn't currently exist for AHK-Cu.
Selected Research
AmpleLab products are cosmetic formulations. They are not medicines and are not intended to diagnose, treat, cure, or prevent any condition. The research referenced is provided for educational purposes.
AmpleLab.